Detailed answers about NTR BIOSENSORS LIMITED, including incorporation, status, business activity, and accounts information.
When was NTR BIOSENSORS LIMITED founded?
NTR BIOSENSORS LIMITED was officially incorporated on 12 September 2025 and is registered under company number 16714716. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NTR BIOSENSORS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NTR BIOSENSORS LIMITED?
NTR BIOSENSORS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NTR BIOSENSORS LIMITED do?
NTR BIOSENSORS LIMITED operates in the following sectors: 32500 - Manufacture of medical and dental instruments and supplies, 47749 - Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c., 72110 - Research and experimental development on biotechnology, 72190 - Other research and experimental development on natural sciences and engineering. These SIC codes provide insight into the company's business activities and industry focus.
What is NTR BIOSENSORS LIMITED's registered address?
The registered office address of NTR BIOSENSORS LIMITED is FLAT 5 CANDLE COURT, HEATH ROAD, HOUNSLOW, GREATER LONDON, ENGLAND, TW3 2NB. This is the official address filed with Companies House for legal and statutory correspondence.
Is NTR BIOSENSORS LIMITED financially stable?
Financial accounts for NTR BIOSENSORS LIMITED are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.